Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models

Research Projects
Organizational Units
Journal Issue
Drug-induced liver injury (DILI) is a challenging clinical event in medicine, particularly because of its ability to present with a variety of phenotypes including that of autoimmune hepatitis or other immune mediated liver injuries. Limited diagnostic and therapeutic tools are available, mostly because its pathogenesis has remained poorly understood for decades. The recent scientific and technological advancements in genomics and immunology are paving the way for a better understanding of the molecular aspects of DILI. This review provides an updated overview of the genetic predisposition and immunological mechanisms behind the pathogenesis of DILI and presents the state-of-the-art experimental models to study DILI at the pre-clinical level.
DeCS Terms
CIE Terms
Inflammation, Autoimmune hepatitis, Autoimmunity, Genetics, Drug-induced liver injury, Inflammation, Hepatitis autoinmune, Autoimmunity, Genética, Enfermedad hepática inducida por sustancias y drogas, Inflamación
Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, et al. Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models. Int J Mol Sci. 2021 Apr 27;22(9):4557